. The company’s pipeline involves 4 medical-stage therapies. Its most Superior drug prospect is ROS1 inhibitor taletrectinib for treating lung cancer. Nuvation is finishing two phase 2 pivotal studies on taletrectinib. That isn’t what I’m most pleased with. I’m prouder that I’ve turned much more than twenty of my https://financefeeds.com/swissquote-sets-ambitious-2028-pre-tax-profit-target-chf-500-million/